Crossject SA ALCJ-Product Pipeline Analysis, 2016 Update

Crossject SA ALCJ-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME86231PD
  • |
  • Pages: 23
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Crossject SA (Crossject) is a medical device company that develops needle-free, pre-filled, single-use and fixed dose injection system based on chemicals and biologics. The company's products include methotrexate, epinephrin, sumatriptan, L15, naloxone, apomorphine, and midazolam. It uses its needle-free injection system to develop a pipeline of supergenerics by combining drug molecules with zeneo. Crossject's zeneo is the exclusive needle-free injection system that can deliver drugs intradermally, subcutaneously and intramuscularly. The company develops supergenerics in the therapeutic area of rheumatoid arthritis, anaphylactic shock and acute migraine. It markets its products through its network of distributors. Crossject is headquartered in Chenove, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Crossject SA

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Crossject SA Company Snapshot 5

Crossject SA Company Overview 5

Crossject SA Pipeline Products and Clinical Trials Overview 6

Crossject SA-Pipeline Analysis Overview 8

Key Facts 8

Crossject SA-Major Products and Services 9

Crossject SA Pipeline Products by Development Stage 10

Crossject SA Pipeline Products Overview 12

Zeneo ID Human Needle-Free Injection Device 12

Zeneo ID Human Needle-Free Injection Device Product Overview 12

Zeneo IM 0.5ml Needle-Free Injection Device 13

Zeneo IM 0.5ml Needle-Free Injection Device Product Overview 13

Zeneo SC 0.5ml Needle-Free Injection Device 14

Zeneo SC 0.5ml Needle-Free Injection Device Product Overview 14

Zeneo SC 0.8ml Needle-Free Injection Device 15

Zeneo SC 0.8ml Needle-Free Injection Device Product Overview 15

Zeneo SC High Viscosity Needle-Free Injection Device 16

Zeneo SC High Viscosity Needle-Free Injection Device Product Overview 16

Crossject SA-Key Competitors 17

Crossject SA-Key Employees 18

Crossject SA-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Crossject SA, Recent Developments 20

Jul 16, 2015: CROSSJECT confirms the development plan for ZENEO Sumatriptan 20

Nov 24, 2014: Crossject Reports Positive Results From Bioequivalence Study With Needle Free ZENEO Methrotrexate 20

Oct 13, 2014: Crossject Appoints Henri de Parseval as Supply Chain Director 21

Jul 07, 2014: CROSSJECT launches bioequivalence clinical study with ZENEO Methrotrexate 21

Dec 09, 2013: Crossject develops a novel version of ZENEO, its needle-free injection device, specifically for patients with rheumatoid arthritis in conjunction with AFP 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23

List of Figures

Crossject SA Pipeline Products by Equipment Type 7

Crossject SA Pipeline Products by Development Stage 10

List of Tables

Crossject SA Pipeline Products and Clinical Trials Overview 6

Crossject SA Pipeline Products by Equipment Type 6

Crossject SA, Key Facts 8

Crossject SA, Major Products and Services 9

Crossject SA Number of Pipeline Products by Development Stage 10

Crossject SA Pipeline Products Summary by Development Stage 11

Zeneo ID Human Needle-Free Injection Device-Product Status 12

Zeneo ID Human Needle-Free Injection Device-Product Description 12

Zeneo IM 0.5ml Needle-Free Injection Device-Product Status 13

Zeneo IM 0.5ml Needle-Free Injection Device-Product Description 13

Zeneo SC 0.5ml Needle-Free Injection Device-Product Status 14

Zeneo SC 0.5ml Needle-Free Injection Device-Product Description 14

Zeneo SC 0.8ml Needle-Free Injection Device-Product Status 15

Zeneo SC 0.8ml Needle-Free Injection Device-Product Description 15

Zeneo SC High Viscosity Needle-Free Injection Device-Product Status 16

Zeneo SC High Viscosity Needle-Free Injection Device-Product Description 16

Crossject SA, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Crossject SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48428
Site License
USD 1,500 INR 65
Corporate User License
USD 2,250 INR 129

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com